CORT
CORT
NASDAQ · Pharmaceuticals

Corcept Therapeutics Inc

$71.63
-7.59 (-9.58%)
As of Nov 5, 9:55 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 10 83%
Hold 1 8%
Sell 1 8%
Price Target
Analyst Price Target +42.9% upside
Low Target $62.31
Average Target $102.33
High Target $121.34
Current Price $71.63
Current
$71.63
Target
$102.33
$62.31 $102.33 avg $121.34
Scenario Analysis
Bear Case
$62.31
-13.0%
Low target
Base Case
$102.33
+42.9%
Avg target
Bull Case
$121.34
+69.4%
High target
Risk/Reward
5.3x
Highly favorable
Price in Context
52-Week High
$126.38
-43.3% from high
52-Week Low
$28.66
+149.9% from low
50-Day SMA
$109.43
-34.5% vs SMA
200-Day SMA
$75.45
-5.1% vs SMA
RSI (14)
17.9
Oversold
Target vs 52W High
$102.33
-19.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -2.5%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +10.0%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.4%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +13.5%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +176.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.3%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +155.6%